Endometrial hyperplasia and endometrial cancer

Obstetrics and Gynecology Clinics of North America

Volumn 23, Issue 2, 1996, Pages 411-456

  Burke, T W ^a   Tortolero Luna, G ^a   Malpica, A ^a   Baker, V V ^a   Whittaker, L ^a   Johnson, E ^a   Mitchell, M F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER STAGING; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MASS SCREENING; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029884507     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)